Nimbus Therapeutics
Presence
Acquisition, funding and merger involving Nimbus Therapeutics.
- Nimbus Therapeutics has just announced a $125 Million fundraising (posted on September 16 2022).
Executives
View the org chart displaying its 21 main executives
Most searched biographies at Nimbus Therapeutics
- Jeb Keiper, Director, President and Chief Executive Officer
- Bruce Booth, Chairman of the Board
- Laura Stoppel, Director
Popular executive movements at Nimbus Therapeutics
- Katharine Knobil has joined the company as Director (posted on March 12 2024).
Create your alert
to follow the executive moves at Nimbus Therapeutics.
Biotechnology
Nimbus Therapeutics has 2,281 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Nimbus Therapeutics
- Nimbus Therapeutics raises $210 million in one of the larger fundraising rounds this year
- Takeda’s $4 Billion Psoriasis Pill Helped Clear Skin in Mid-Stage Study
- Nimbus CEO Jeb Keiper on negotiating a $4B deal and building an unorthodox biotech startup
- Nimbus raises $125M to advance rival to Bristol Myers’ new psoriasis drug
- UNCF Virtual Summit to Create Pathways for African American Opportunities in the Greater Boston Area Life Sciences Ecosystem | UNCF
Social media about Nimbus Therapeutics
- Nimbus Therapeutics on Wikipedia, Google News & Yahoo Finance
- Nimbus Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jeb Keiper 
Call Nimbus Therapeutics at +1 857...
